21 related articles for article (PubMed ID: 33847682)
1. [Prognostic analysis of childhood T-lymphoblastic lymphoma treated with leukemia regimen].
Hou SM; Shao JB; Li H; Zhang N; Zhu JS; Wang D; Fu P
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):469-475. PubMed ID: 38802906
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic Value of Average Daily Platelet Increase in Childhood B-cell Acute Lymphoblastic Leukemia Patients].
Chen L; Chen Q; Wang YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):413-417. PubMed ID: 35395972
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.
Rolf N; Smolen KK; Kariminia A; Velenosi A; Fidanza M; Strahlendorf C; Seif AE; Reid GSD
Cancer Immunol Immunother; 2018 Feb; 67(2):225-236. PubMed ID: 29052781
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
Zhao Y; Li C; Cai C; Fu H; Zhao Z; Han J; Zhang F; Wang J
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e739-e745. PubMed ID: 36897339
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease.
Shalini CNS; Suman FR; Jacob JS; Rajendran R; Scott JX; Latha MS
Hematol Transfus Cell Ther; 2018; 40(4):310-316. PubMed ID: 30370408
[TBL] [Abstract][Full Text] [Related]
6. Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers.
Carvalho MPSS; Magalhães-Gama F; Loiola BP; Neves JCF; Araújo ND; Silva FS; Catão CLS; Alves EB; Pimentel JPD; Barbosa MNS; Fraiji NA; Teixeira-Carvalho A; Martins-Filho OA; Costa AG; Malheiro A
Front Oncol; 2023; 13():1290505. PubMed ID: 38107068
[TBL] [Abstract][Full Text] [Related]
7. Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia.
Li Y; Song Z; Sun X; Tang J; Zhou X
Biomol Biomed; 2023 Nov; 23(6):956-967. PubMed ID: 37401750
[TBL] [Abstract][Full Text] [Related]
8. Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia.
Dai Q; Shi R; Zhang G; Yang H; Wang Y; Ye L; Peng L; Guo S; He J; Jiang Y
Medicine (Baltimore); 2021 Apr; 100(15):e25548. PubMed ID: 33847682
[TBL] [Abstract][Full Text] [Related]
9. Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Zeidler L; Zimmermann M; Möricke A; Meissner B; Bartels D; Tschan C; Schrauder A; Cario G; Goudeva L; Jäger S; Ratei R; Ludwig WD; Teigler-Schlegel A; Skokowa J; Koehler R; Bartram CR; Riehm H; Schrappe M; Welte K; Stanulla M
Haematologica; 2012 Mar; 97(3):402-9. PubMed ID: 22058224
[TBL] [Abstract][Full Text] [Related]
10. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis.
Dai Q; Zhang G; Yang H; Wang Y; Ye L; Peng L; Shi R; Guo S; He J; Jiang Y
Medicine (Baltimore); 2021 Jan; 100(4):e24518. PubMed ID: 33530278
[TBL] [Abstract][Full Text] [Related]
12. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
